In recent years, extensive debate has centered around the possibility of further extending the scope of hepatic resection. With research now demonstrating the potential value of extended resection, will more patients be offered this as a treatment option? Are there common complications to consider when evaluating a candidate for this surgery? Dr. Alan Hemming, professor of surgery and chief of transplantation and hepatobiliary surgery at the University of Florida College of Medicine, explains the next steps toward entrenching extended resection in our arsenal of treatment for hepatic disease. Dr. Mark Nolan Hill hosts.
